comprehensive -WSS

comprehensive

author：explore 2025-08-19 15:02:22 - browse：125

a person uses a smart phone with both fingers in the dark – first opinion coverage from STAT — Adobe

In May, a National Public Radio story asked, “Can a chatbot help people with eating disorders as well as another human?”

It focused on a chatbot that we developed to prevent eating disorders and help people with body image concerns and who are otherwise not likely to have access to other resources. We’ve committed our careers to increasing detection of eating disorders and access to care, and we received research funding from the National Eating Disorders Association (NEDA) to create and evaluate a chatbot called Tessa in hopes of preventing eating disorders and helping to address the problem that once individuals develop eating disorders, less than 20% ever receive any care.

The NPR story and coverage that followed led to a tremendous backlash for a couple of reasons. Some of those reasons are fair and are related to a technical problem — more on that in a minute.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Florida officials tell state schools to teach AP Psychology 'in its entirety'

WSS

Readout Newsletter: CG Oncology IPO, Eli Lilly, Tesla, Merck

Philips to halt sales of sleep apnea machines in U.S.

Alnylam reports growth in sales of rare disease treatments

New clues to why women have higher risk of autoimmune disorders

Medicare drug price negotiation legal challenge met with skepticism

'Null' research findings aren't empty of meaning. Let's publish them

hotspot

comprehensive

Wikipedia

Novavax promises a turnaround & Lilly roils the obesity market

FDA scientists endorse Pfizer/BioNTech Covid

In Memoriam: Notable people who died in 2023

Medicare Advantage insurers face 0.2% cut to 2025 payments

Peter Hotez and the public health issue of online harassment

Philips to halt sales of sleep apnea machines in U.S.

The high cost of giving birth even with insurance

Medicare slashes safety net hospital payments by nearly $1 billion

FDA approval of Sarepta Duchenne genetic therapy gives me hope

FDA approves Sage Therapeutics’ rapid

knowledge

Readout Newsletter: The latest on Novavax, Merck, Bluebird

Syphilis numbers in the United States reach record heights

Readout Newsletter: CG Oncology IPO, Eli Lilly, Tesla, Merck

Biogen walks away from Aduhelm, years after polarizing approval

Medicare Advantage insurers face 0.2% cut to 2025 payments

Reconstructing family trees of blood cells may help predict disease

Wikipedia

explore

hotspot

knowledge